Over the past decades improvements in computers and networking, radiation therapy treatment planning software, and medical imaging modalities (CT, MRI, US, and PET) have been incorporated into radiation therapy practice. These improvements have led to the development of image guided radiation therapy (“IGRT”). IGRT is radiation therapy that uses cross-sectional images of the patient's internal anatomy to better target the radiation dose in the tumor while reducing the radiation exposure to healthy organs. The radiation dose delivered to the tumor is controlled with intensity modulated radiation therapy (“IMRT”), which involves changing the size, shape, and intensity of the radiation beam to conform to the size, shape, and location of the patient's tumor. IGRT and IMRT lead to improved control of the tumor while simultaneously reducing the potential for acute side effects due to irradiation of healthy tissue surrounding the tumor.
IMRT is becoming the standard of care in several countries. However, in many situations, IMRT is not used to treat a patient due to time, resources, and billing constraints. Daily images of the patient can be used to guarantee that the high gradients generated by IMRT plans are located on the correct position for patient treatment. Also these images can provide necessary information to adapt the plan online or offline if needed.
It is commonly known in the field of radiation therapy that there are many sources of uncertainty and change that can occur during a course of a patient's treatment. Some of these sources represent random errors, such as small differences in a patient's setup position each day. Other sources are attributable to physiological changes, which might occur if a patient's tumor regresses or the patient loses weight during therapy. A third possible category regards motion. Motion can potentially overlap with either of the other categories, as some motion might be more random and unpredictable, such as a patient coughing or passing gas, whereas other motion can be more regular, such as breathing motion, sometimes.
In radiation therapy, uncertainties can affect the quality of a patient's treatment. For example, when delivering a treatment dose to a target region, it is standard practice to also treat a high-dose “margin” region about the target. This helps ensure that the target receives the desired dose, even if its location changes during the course of the treatment, or even during a single fraction. The less definite a target's location, the larger the margins that typically need to be used.
Adaptive radiation therapy generally refers to the concept of using feedback during the course of radiation therapy treatment to improve future treatments. Feedback can be used in off-line adaptive therapy processes and on-line adaptive therapy processes. Off-line adaptive therapy processes occur while the patient is not being treated, such as in between treatment fractions. In one version of this, during each fraction, a new CT image of the patient is acquired before or after each of the fractions. After the images are acquired from the first few treatment fractions, the images are evaluated to determine an effective envelope of the multi-day locations of target structures. A new plan can then be developed to better reflect the range of motion of the target structure, rather than using canonical assumptions of motion. A more complex version of off-line adaptive therapy is to recalculate the delivered dose after each fraction and accumulate these doses, potentially utilizing deformation techniques, during this accumulation to account for internal motion. The accumulated dose can then be compared to the planned dose, and if any discrepancies are noted, subsequent fractions can be modified to account for the changes.
On-line adaptive therapy processes typically occur while the patient is in the treatment room, and potentially, but not necessarily, during a treatment delivery. For example, some radiation therapy treatment systems are equipped with imaging systems, such as on-line CT or x-ray systems. These systems can be used prior to treatment to validate or adjust the patient's setup for the treatment delivery. The imaging systems may also be used to adapt the treatment during the actual treatment delivery. For example, an imaging system potentially can be used concurrently with treatment to modify the treatment delivery to reflect changes in patient anatomy.
One aspect of the present invention is to disclose new opportunities for the application of adaptive therapy techniques, and additional aspects are to present novel methods for adaptive therapy. In particular, adaptive therapy has typically focused on feedback to modify a patient's treatment, but the present invention focuses on adaptive therapy processes being used in a quality assurance context. This is particularly true in the context of whole-system verification.
For example, a detector can be used to collect information indicating how much treatment beam has passed through the patient, from which the magnitude of the treatment output can be determined as well as any radiation pattern that was used for the delivery. The benefit of this delivery verification process is that it enables the operator to detect errors in the machine delivery, such as an incorrect leaf pattern or machine output.
However, validating that the machine is functioning properly does not itself ensure proper delivery of a treatment plan, as one also needs to validate that the external inputs used to program the machine are effective and consistent. Thus, one aspect of the invention includes the broader concept of an adaptive-type feedback loop for improved quality assurance of the entire treatment process. In this aspect, the invention includes the steps of positioning the patient for treatment and using a method for image-guidance to determine the patient's position, repositioning the patient as necessary for treatment based upon the image-guidance, and beginning treatment. Then, either during or after treatment, recalculating the patient dose and incorporating the patient image information that had been collected before or during treatment. After completion of these steps, quality assurance data is collected to analyze the extent to which the delivery was not only performed as planned, but to validate that the planned delivery is reasonable in the context of the newly available data. In this regard, the concept of feedback is no longer being used to indicate changes to the treatment based on changes in the patient or delivery, but to validate the original delivery itself.
As an example, it is possible that a treatment plan might be developed for a patient, but that the image used for planning became corrupted, such as by applying an incorrect density calibration. In this case, the treatment plan will be based upon incorrect information, and might not deliver the correct dose to the patient. Yet, many quality assurance techniques will not detect this error because they will verify that the machine is operating as instructed, rather than checking whether the instructions to the machine are based on correct input information. Likewise, some adaptive therapy techniques could be applied to this delivery, but if the calibration problem of this example persisted, then the adapted treatments would suffer from similar flaws.
There are a number of processes that can be used to expand the use of feedback for quality assurance purposes. For example, in one embodiment, this process would include the delivery verification techniques described above. The validation of machine performance that these methods provide is a valuable component of a total-system quality assurance toolset. Moreover, the delivery verification processes can be expanded to analyze other system errors, such as deliveries based on images with a truncated field-of-view.
This method of quality assurance also benefits from the use of registration, and in particular, deformable registration, techniques. Registration is a method for determining the correlation between locations of a patient's anatomy or physiology across multiple images, and deformable registration is a method of doing this to account for non-rigid changes in anatomy between the images, phases, or times. As mentioned before, an important step in this method of quality assurance is the recalculation of dose based upon on-line images and feedback from the machine. When analyzing these doses, it is useful to accumulate the dose across multiple treatments to determine if any errors are being exacerbated or if they are mitigating each other.
It should be noted that while the invention presented is not fundamentally tied to adaptive therapy, in that these quality assurance processes can be applied without an adaptive therapy process in place, or adaptive therapy can be performed without these QA methods, there can be added benefits to using adaptive therapy in addition to these techniques. Therefore, if discrepancies are noted by using delivery feedback, these discrepancies can be rectified by any number of mechanisms either on-line or between fractions. The discrepancies to be remedied can extend beyond problems identified with the machine itself, for example, to inconsistencies with the process, or flawed inputs that are used to program the machine for a given treatment plan.
In one embodiment, the invention provides a method of placing constraints on a deformation map. The method comprises the acts of generating a deformation map between two images, identifying a defined structure in one of the images, applying the deformation map to relate the defined structure from the one image onto the other image to create a deformation-based defined structure, modifying the deformation-based defined structure, and updating the deformation map in response to the step of modifying the deformation-based defined structure.
In another embodiment, the invention provides a method of placing constraints on a deformation map. The method comprises the acts of generating a deformation map between two images, identifying a defined structure in one of the images, applying the deformation map to relate the defined structure from the one image onto the other image to create a deformation-based defined structure, modifying the deformation-based defined structure, updating the deformation map in response to the step of modifying the deformation-based defined structure, and generating a contour based on the updated deformation map.
In another embodiment, the invention provides a method of placing constraints on a deformation map. The method comprises the acts of a method of placing constraints on a deformation map. The method comprises the acts of generating a first contour set, generating a second contour set, and generating a deformation map between the first contour set and the second contour set.
Other aspects of the invention will become apparent by consideration of the detailed description and accompanying drawings.
Before any embodiments of the invention are explained in detail, it is to be understood that the invention is not limited in its application to the details of construction and the arrangement of components set forth in the following description or illustrated in the following drawings. The invention is capable of other embodiments and of being practiced or of being carried out in various ways. Also, it is to be understood that the phraseology and terminology used herein is for the purpose of description and should not be regarded as limiting. The use of “including,” “comprising,” or “having” and variations thereof herein is meant to encompass the items listed thereafter and equivalents thereof as well as additional items. Unless specified or limited otherwise, the terms “mounted,” “connected,” “supported,” and “coupled” and variations thereof are used broadly and encompass both direct and indirect mountings, connections, supports, and couplings. Further, “connected” and “coupled” are not restricted to physical or mechanical connections or couplings.
Although directional references, such as upper, lower, downward, upward, rearward, bottom, front, rear, etc., may be made herein in describing the drawings, these references are made relative to the drawings (as normally viewed) for convenience. These directions are not intended to be taken literally or limit the present invention in any form. In addition, terms such as “first”, “second”, and “third” are used herein for purposes of description and are not intended to indicate or imply relative importance or significance.
In addition, it should be understood that embodiments of the invention include both hardware, software, and electronic components or modules that, for purposes of discussion, may be illustrated and described as if the majority of the components were implemented solely in hardware. However, one of ordinary skill in the art, and based on a reading of this detailed description, would recognize that, in at least one embodiment, the electronic based aspects of the invention may be implemented in software. As such, it should be noted that a plurality of hardware and software based devices, as well as a plurality of different structural components may be utilized to implement the invention. Furthermore, and as described in subsequent paragraphs, the specific mechanical configurations illustrated in the drawings are intended to exemplify embodiments of the invention and that other alternative mechanical configurations are possible.
The radiation module 22 can also include a modulation device 34 operable to modify or modulate the radiation beam 30. The modulation device 34 provides the modulation of the radiation beam 30 and directs the radiation beam 30 toward the patient 14. Specifically, the radiation beam 34 is directed toward a portion of the patient. Broadly speaking, the portion may include the entire body, but is generally smaller than the entire body and can be defined by a two-dimensional area and/or a three-dimensional volume. A portion desired to receive the radiation, which may be referred to as a target 38 or target region, is an example of a region of interest. Another type of region of interest is a region at risk. If a portion includes a region at risk, the radiation beam is preferably diverted from the region at risk. The patient 14 may have more than one target region that needs to receive radiation therapy. Such modulation is sometimes referred to as intensity modulated radiation therapy (“IMRT”).
The modulation device 34 can include a collimation device 42 as illustrated in
In one embodiment, and illustrated in
The radiation therapy treatment system 10 can also include a detector 78, e.g., a kilovoltage or a megavoltage detector, operable to receive the radiation beam 30. The linear accelerator 26 and the detector 78 can also operate as a computed tomography (CT) system to generate CT images of the patient 14. The linear accelerator 26 emits the radiation beam 30 toward the target 38 in the patient 14. The target 38 absorbs some of the radiation. The detector 78 detects or measures the amount of radiation absorbed by the target 38. The detector 78 collects the absorption data from different angles as the linear accelerator 26 rotates around and emits radiation toward the patient 14. The collected absorption data is transmitted to the computer 74 to process the absorption data and to generate images of the patient's body tissues and organs. The images can also illustrate bone, soft tissues, and blood vessels.
The CT images can be acquired with a radiation beam 30 that has a fan-shaped geometry, a multi-slice geometry or a cone-beam geometry. In addition, the CT images can be acquired with the linear accelerator 26 delivering megavoltage energies or kilovoltage energies. It is also noted that the acquired CT images can be registered with previously acquired CT images (from the radiation therapy treatment system 10 or other image acquisition devices, such as other CT scanners, MRI systems, and PET systems). For example, the previously acquired CT images for the patient 14 can include identified targets 38 made through a contouring process. The newly acquired CT images for the patient 14 can be registered with the previously acquired CT images to assist in identifying the targets 38 in the new CT images. The registration process can use rigid or deformable registration tools.
In some embodiments, the radiation therapy treatment system 10 can include an x-ray source and a CT image detector. The x-ray source and the CT image detector operate in a similar manner as the linear accelerator 26 and the detector 78 as described above to acquire image data. The image data is transmitted to the computer 74 where it is processed to generate images of the patient's body tissues and organs.
The radiation therapy treatment system 10 can also include a patient support, such as a couch 82 (illustrated in
The computer 74, illustrated in
The computer 74 can include any suitable input/output device adapted to be accessed by medical personnel. The computer 74 can include typical hardware such as a processor, I/O interfaces, and storage devices or memory. The computer 74 can also include input devices such as a keyboard and a mouse. The computer 74 can further include standard output devices, such as a monitor. In addition, the computer 74 can include peripherals, such as a printer and a scanner.
The computer 74 can be networked with other computers 74 and radiation therapy treatment systems 10. The other computers 74 may include additional and/or different computer programs and software and are not required to be identical to the computer 74, described herein. The computers 74 and radiation therapy treatment system 10 can communicate with a network 94. The computers 74 and radiation therapy treatment systems 10 can also communicate with a database(s) 98 and a server(s) 102. It is noted that the software program(s) 90 could also reside on the server(s) 102.
The network 94 can be built according to any networking technology or topology or combinations of technologies and topologies and can include multiple sub-networks. Connections between the computers and systems shown in
Communication between the computers and systems shown in
The two-way arrows in
The software program 90 includes a plurality of modules illustrated in
The software program 90 includes a treatment plan module 106 operable to generate a treatment plan for the patient 14 based on data input to the system 10 by medical personnel. The data includes one or more images (e.g., planning images and/or pre-treatment images) of at least a portion of the patient 14. The treatment plan module 106 separates the treatment into a plurality of fractions and determines the radiation dose for each fraction or treatment based on the prescription input by medical personnel. The treatment plan module 106 also determines the radiation dose for the target 38 based on various contours drawn around the target 38. Multiple targets 38 may be present and included in the same treatment plan.
The software program 90 also includes an image module 110 operable to acquire images of at least a portion of the patient 14. Prior to delivery of the treatment plan, the image module 110 can instruct the on-board image device, such as a CT imaging device to acquire one or more pre-treatment images of the patient 14 before treatment commences. Other off-line imaging devices or systems may be used to acquire pre-treatment images of the patient 14, such as non-quantitative CT, MRI, PET, SPECT, ultrasound, transmission imaging, fluoroscopy, RF-based localization, and the like. The acquired pre-treatment image(s) can be used for registration of the patient 14 and/or to generate a deformation map to identify the differences between one or more of the planning images and one or more of the pre-treatment images.
The software program 90 also can include a deformation module 114 operable to receive data, such as image data from the image module 110 and the treatment planning module 106 and other patient and system data from the treatment plan module 106 to generate a deformation map of the images. The deformation module 114 can use deformation techniques to determine an accumulation of radiation dose for all of the delivered treatments.
A deformation map can be utilized to relate a plurality of images for dose calculation purposes. For example, a deformation map can relate a planning image that is useful for dose calculation, and an on-line image, which has qualitative value but less direct utility for dose calculation. This relationship can then be used to “remap” the more quantitative image to the qualitative shape of the on-line or less quantitative image. The resulting remapped image would be more appropriate than either of the planning image or the on-line image for dose calculation or quantitative applications as it would have the quantitative benefits of the first image, but with the updated anatomical information as contained in the second image. This is useful in a variety of cases, such as where the first image (e.g., a planning image) is a CT image and where the second image lacks quantitative image values (e.g., MRI, PET, SPECT, ultrasound, or non-quantitative CT, etc. images). A deformation map also can relate a reference image, such as a 3D image (e.g., a planning image or a pre-treatment image), and a time-based series of images, such as a 4D CT image to determine an amount of radiation dose delivered to the patient 14.
The deformation module 114 can correct for geometrical distortion, imperfections, and/or incompleteness in lieu of, or in addition to, quantitative limitations. For example, a current MRI image that represents anatomy well but includes geometric distortion might be remapped to a CT image that is not distorted. Or, multiple images can be used to simultaneously correct for distortion while representing anatomical changes.
The deformation map can be used to calculate radiation dose on patient images acquired after the planning image. It is also useful to accumulate the doses for multiple delivered fractions. The doses can be added based upon the location of the doses in physical space, but another method is to incorporate deformation methods into the process so as to add doses based upon the structures that received the dose, even if the structures have changed location. The deformation module 114 can calculate the doses of radiation that the patient 14 has received from previously delivered fractions.
A deformation map can be generated for purposes of defining a contour around a target 38. The software program 90 can include a contour module 118 operable to generate one or more contours on an image. Generally, medical personnel manually define a contour around a target 38 on a planning image. This process is time consuming. Newly acquired images (e.g., pre-treatment images) do not have the defined contour(s). It is desirable to generate contours on the new image based upon an old image that includes the contour(s). A deformation map can be used to assist in the contouring process by transferring the contour(s) from an old image onto a new image and can create time savings for the medical personnel while providing quality assurance measures.
The contour can be generated automatically or semi-automatically for a new image (e.g., a pre-treatment image).
A similar family of template-based contouring algorithms has been developed to generate contours for newly-available images, based upon previously available sets of images and contours. These template-based algorithms might contour a new patient image based upon a previous patient image and contour, or potentially based upon a canonical or atlas patient image and contour. This can be performed for adaptive therapy as a means to accumulate doses in daily images, each with automatic daily contours. It is an aspect of this invention to apply deformation-based contouring or template-based contouring to radiation therapy quality assurance and adaptive therapy. In this aspect, the invention applies these techniques to the particular wealth of image data and types of images that arise during image-guided radiation therapy. Specifically, this includes deformation and template-based contouring of multiple images of the same patient in which contour sets might only exist for one of the images. These multiple images of the patient may arise from use of an on-line or in-room patient imaging system, with images potentially taken on different days, or these images might derive from a “4D” imaging system such as a CT scanner, in which each image represents a phase of motion, such as a breathing phase. It should also be noted that the on-line or in-room imaging system might be the same, a similar, or a different modality from the reference image. For example, the reference image might be a CT image, whereas the on-line image could be a CT image, a cone-beam CT image, a megavoltage CT image, a MRI image, an ultrasound image, or an image generated by a different system or device. By porting these contouring techniques to the applications of quality assurance and adaptive therapy, it is possible to both save a considerable amount of time from the contouring of images, and this method can also improve the consistency of contours across multiple images of the same patient (taken at different times or representing different phases).
Another benefit of this process is that the contours generated provide a validation of the deformation process. If the generated contours closely reflect contours that one would manually draw, then it is a good indication that the deformation process is reasonable; whereas if the automatic contours are less relevant, it indicates to the medical personnel that perhaps the deformation is inappropriate, but also provides the medical personnel an opportunity to verify the manual contours to check for mistakes or inconsistencies. Another aspect of this invention is that the deformation-based contours can be used as a rough-draft of the contours for the adaptive process, and manually edited to reflect the desired contours for the on-line images. When doing this, the deformation process can then be re-run, constraining the deformation map to match the initial contours to the manually-edited automatic contours, and this helps direct consistent results through the rest of the image.
While the deformation process above was described in the context of registering one image to another image, it can also work with deformably registering a set of two or more images with another set of one or more images. For example, if there are two pairs of images, each pair comprising an MRI and a CT image, then the deformation map can register the two MRI images together in regions where the MRI has more information, and the CT images together where the CT has more information. These deformations could then be combined. Or deformation maps between the images could be used together, such as for using the CT deformation maps to correct for geometric distortion, imperfections, and/or incompleteness in the MRI images and deformations, and then, having corrected that distortion, imperfection, and/or incompleteness using the MRI deformation maps for better analysis of soft-tissue motion. In a general sense, this process enables imaging improvement via deformation, as poor images can be better understood, and therefore improved, by applying deformation techniques that indicate information like anatomical sizes, shapes, and content. This information can be incorporated into image reconstruction, modification, or enhancement processes.
The software program 90 also includes a treatment delivery module 154 operable to instruct the radiation therapy treatment system 10 to deliver radiation therapy to the patient 14 according to the treatment plan. The treatment delivery module 154 can generate and transmit instructions to the gantry 18, the linear accelerator 26, the modulation device 34, and the drive system 86 to deliver radiation to the patient 14. The instructions coordinate the necessary movements of the gantry 18, the modulation device 34, and the drive system 86 to deliver the radiation beam 30 to the proper target in the proper amount as specified in the treatment plan.
The treatment delivery module 154 also calculates the appropriate pattern, position, and intensity of the radiation beam 30 to be delivered, to match the prescription as specified by the treatment plan. The pattern of the radiation beam 30 is generated by the modulation device 34, and more particularly by movement of the plurality of leaves in the multi-leaf collimator. The treatment delivery module 154 can utilize canonical, predetermined or template leaf patterns to generate the appropriate pattern for the radiation beam 30 based on the treatment parameters. The treatment delivery module 154 can also include a library of patterns for typical cases that can be accessed in which to compare the present patient data to determine the pattern for the radiation beam 30.
Various features and advantages of the invention are set forth in the following claims.
This application claims priority to U.S. Provisional Patent Application No. 60/701,580, filed on Jul. 22, 2005, titled SYSTEM AND METHOD FOR FEEDBACK GUIDED QUALITY ASSURANCE AND ADAPTATIONS TO RADIATION THERAPY TREATMENT, the entire contents of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3949265 | Holl | Apr 1976 | A |
3964467 | Rose | Jun 1976 | A |
4006422 | Schriber | Feb 1977 | A |
4032810 | Eastham et al. | Jun 1977 | A |
4149081 | Seppi | Apr 1979 | A |
4181894 | Pottier | Jan 1980 | A |
4189470 | Rose | Feb 1980 | A |
4208185 | Sawai et al. | Jun 1980 | A |
4273867 | Lin et al. | Jun 1981 | A |
4314180 | Salisbury | Feb 1982 | A |
4335465 | Christiansen et al. | Jun 1982 | A |
4388560 | Robinson et al. | Jun 1983 | A |
4393334 | Glaser | Jul 1983 | A |
4395631 | Salisbury | Jul 1983 | A |
4401765 | Craig et al. | Aug 1983 | A |
4426582 | Orloff et al. | Jan 1984 | A |
4446403 | Cuomo et al. | May 1984 | A |
4480042 | Craig et al. | Oct 1984 | A |
4570103 | Schoen | Feb 1986 | A |
4664869 | Mirzadeh et al. | May 1987 | A |
4703018 | Craig et al. | Oct 1987 | A |
4715056 | Vlasbloem et al. | Dec 1987 | A |
4736106 | Kashy et al. | Apr 1988 | A |
4752692 | Jergenson et al. | Jun 1988 | A |
4754760 | Fukukita et al. | Jul 1988 | A |
4815446 | McIntosh | Mar 1989 | A |
4818914 | Brodie | Apr 1989 | A |
4868844 | Nunan | Sep 1989 | A |
4870287 | Cole et al. | Sep 1989 | A |
4879518 | Broadhurst | Nov 1989 | A |
4912731 | Nardi | Mar 1990 | A |
4936308 | Fukukita et al. | Jun 1990 | A |
4987309 | Klasen et al. | Jan 1991 | A |
4998268 | Winter | Mar 1991 | A |
5003998 | Collett | Apr 1991 | A |
5008907 | Norman et al. | Apr 1991 | A |
5012111 | Ueda | Apr 1991 | A |
5065315 | Garcia | Nov 1991 | A |
5073913 | Martin | Dec 1991 | A |
5084682 | Swenson et al. | Jan 1992 | A |
5107222 | Tsuzuki | Apr 1992 | A |
5124658 | Adler | Jun 1992 | A |
5210414 | Wallace et al. | May 1993 | A |
5250388 | Schoch, Jr. et al. | Oct 1993 | A |
5317616 | Swerdloff et al. | May 1994 | A |
5335255 | Seppi et al. | Aug 1994 | A |
5346548 | Mehta | Sep 1994 | A |
5351280 | Swerdloff et al. | Sep 1994 | A |
5382914 | Hamm et al. | Jan 1995 | A |
5391139 | Edmundson | Feb 1995 | A |
5394452 | Swerdloff et al. | Feb 1995 | A |
5405309 | Carden, Jr. | Apr 1995 | A |
5442675 | Swerdloff et al. | Aug 1995 | A |
5453310 | Andersen et al. | Sep 1995 | A |
5466587 | Fitzpatrick-McElligott et al. | Nov 1995 | A |
5471516 | Nunan | Nov 1995 | A |
5483122 | Derbenev et al. | Jan 1996 | A |
5489780 | Diamondis | Feb 1996 | A |
5523578 | Herskovic | Jun 1996 | A |
5528650 | Swerdloff et al. | Jun 1996 | A |
5548627 | Swerdloff et al. | Aug 1996 | A |
5576602 | Hiramoto et al. | Nov 1996 | A |
5578909 | Billen | Nov 1996 | A |
5581156 | Roberts et al. | Dec 1996 | A |
5596619 | Carol | Jan 1997 | A |
5596653 | Kurokawa | Jan 1997 | A |
5621779 | Hughes et al. | Apr 1997 | A |
5622187 | Carol | Apr 1997 | A |
5625663 | Swerdloff et al. | Apr 1997 | A |
5627041 | Shartle | May 1997 | A |
5641584 | Andersen et al. | Jun 1997 | A |
5647663 | Holmes | Jul 1997 | A |
5651043 | Tsuyuki et al. | Jul 1997 | A |
5661377 | Mishin et al. | Aug 1997 | A |
5661773 | Swerdloff et al. | Aug 1997 | A |
5667803 | Paronen et al. | Sep 1997 | A |
5668371 | Deasy et al. | Sep 1997 | A |
5673300 | Reckwerdt et al. | Sep 1997 | A |
5692507 | Seppi et al. | Dec 1997 | A |
5695443 | Brent et al. | Dec 1997 | A |
5712482 | Gaiser et al. | Jan 1998 | A |
5721123 | Hayes et al. | Feb 1998 | A |
5724400 | Swerdloff et al. | Mar 1998 | A |
5729028 | Rose | Mar 1998 | A |
5734168 | Yao | Mar 1998 | A |
5747254 | Pontius | May 1998 | A |
5751781 | Brown et al. | May 1998 | A |
5753308 | Andersen et al. | May 1998 | A |
5754622 | Hughes | May 1998 | A |
5754623 | Seki | May 1998 | A |
5760395 | Johnstone | Jun 1998 | A |
5802136 | Carol | Sep 1998 | A |
5811944 | Sampayan et al. | Sep 1998 | A |
5815547 | Shepherd et al. | Sep 1998 | A |
5818058 | Nakanishi et al. | Oct 1998 | A |
5818902 | Yu | Oct 1998 | A |
5820553 | Hughes | Oct 1998 | A |
5821051 | Androphy et al. | Oct 1998 | A |
5821705 | Caporaso et al. | Oct 1998 | A |
5834454 | Kitano et al. | Nov 1998 | A |
5836905 | Lemelson et al. | Nov 1998 | A |
5842175 | Andros et al. | Nov 1998 | A |
5866912 | Slater et al. | Feb 1999 | A |
5870447 | Powell et al. | Feb 1999 | A |
5877023 | Sautter et al. | Mar 1999 | A |
5877192 | Lindberg et al. | Mar 1999 | A |
5912134 | Shartle | Jun 1999 | A |
5920601 | Nigg et al. | Jul 1999 | A |
5953461 | Yamada | Sep 1999 | A |
5962995 | Avnery | Oct 1999 | A |
5963615 | Egley et al. | Oct 1999 | A |
5969367 | Hiramoto et al. | Oct 1999 | A |
5977100 | Kitano et al. | Nov 1999 | A |
5983424 | Naslund | Nov 1999 | A |
5986274 | Akiyama et al. | Nov 1999 | A |
6011825 | Welch et al. | Jan 2000 | A |
6020135 | Levine et al. | Feb 2000 | A |
6020538 | Han et al. | Feb 2000 | A |
6029079 | Cox et al. | Feb 2000 | A |
6038283 | Carol et al. | Mar 2000 | A |
6049587 | Leksell et al. | Apr 2000 | A |
6066927 | Koudijs | May 2000 | A |
6069459 | Koudijs | May 2000 | A |
6071748 | Modlin et al. | Jun 2000 | A |
6094760 | Nonaka et al. | Aug 2000 | A |
6127688 | Wu | Oct 2000 | A |
6152599 | Salter | Nov 2000 | A |
6171798 | Levine et al. | Jan 2001 | B1 |
6178345 | Vilsmeier et al. | Jan 2001 | B1 |
6197328 | Yanagawa | Mar 2001 | B1 |
6198957 | Green | Mar 2001 | B1 |
6200959 | Haynes et al. | Mar 2001 | B1 |
6204510 | Ohkawa | Mar 2001 | B1 |
6207400 | Kwon | Mar 2001 | B1 |
6218675 | Akiyama et al. | Apr 2001 | B1 |
6222905 | Yoda et al. | Apr 2001 | B1 |
6241670 | Nambu | Jun 2001 | B1 |
6242747 | Sugitani et al. | Jun 2001 | B1 |
6264825 | Blackburn et al. | Jul 2001 | B1 |
6265837 | Akiyama et al. | Jul 2001 | B1 |
6279579 | Riaziat et al. | Aug 2001 | B1 |
6291823 | Doyle et al. | Sep 2001 | B1 |
6316776 | Hiramoto et al. | Nov 2001 | B1 |
6319469 | Mian et al. | Nov 2001 | B1 |
6322249 | Wofford et al. | Nov 2001 | B1 |
6331194 | Elizondo-Decanini et al. | Dec 2001 | B1 |
6345114 | Mackie et al. | Feb 2002 | B1 |
6360116 | Jackson, Jr. et al. | Mar 2002 | B1 |
6385286 | Fitchard et al. | May 2002 | B1 |
6385288 | Kanematsu | May 2002 | B1 |
6393096 | Carol et al. | May 2002 | B1 |
6405072 | Cosman | Jun 2002 | B1 |
6407505 | Bertsche | Jun 2002 | B1 |
6417178 | Klunk et al. | Jul 2002 | B1 |
6424856 | Vilsmeier et al. | Jul 2002 | B1 |
6428547 | Vilsmeier et al. | Aug 2002 | B1 |
6433349 | Akayama et al. | Aug 2002 | B2 |
6438202 | Olivera et al. | Aug 2002 | B1 |
6455844 | Meyer | Sep 2002 | B1 |
6462490 | Matsuda et al. | Oct 2002 | B1 |
6465957 | Whitham et al. | Oct 2002 | B1 |
6466644 | Hughes et al. | Oct 2002 | B1 |
6469058 | Grove et al. | Oct 2002 | B1 |
6472834 | Hiramoto et al. | Oct 2002 | B2 |
6473490 | Siochi | Oct 2002 | B1 |
6475994 | Tomalia et al. | Nov 2002 | B2 |
6482604 | Kwon | Nov 2002 | B2 |
6484144 | Martin et al. | Nov 2002 | B2 |
6487274 | Bertsche | Nov 2002 | B2 |
6493424 | Whitham | Dec 2002 | B2 |
6497358 | Walsh | Dec 2002 | B1 |
6498011 | Hohn et al. | Dec 2002 | B2 |
6500343 | Siddiqi | Dec 2002 | B2 |
6504899 | Pugachev et al. | Jan 2003 | B2 |
6510199 | Hughes et al. | Jan 2003 | B1 |
6512942 | Burdette et al. | Jan 2003 | B1 |
6516046 | Frohlich et al. | Feb 2003 | B1 |
6527443 | Vilsmeier et al. | Mar 2003 | B1 |
6531449 | Khojasteh et al. | Mar 2003 | B2 |
6535837 | Schach Von Wittenau | Mar 2003 | B1 |
6552338 | Doyle | Apr 2003 | B1 |
6558961 | Sarphie et al. | May 2003 | B1 |
6560311 | Shepard et al. | May 2003 | B1 |
6562376 | Hooper et al. | May 2003 | B2 |
6584174 | Schubert et al. | Jun 2003 | B2 |
6586409 | Wheeler | Jul 2003 | B1 |
6605297 | Nadachi et al. | Aug 2003 | B2 |
6611700 | Vilsmeier et al. | Aug 2003 | B1 |
6617768 | Hansen | Sep 2003 | B1 |
6618467 | Ruchala et al. | Sep 2003 | B1 |
6621889 | Mostafavi | Sep 2003 | B1 |
6633686 | Bakircioglu et al. | Oct 2003 | B1 |
6634790 | Salter, Jr. | Oct 2003 | B1 |
6636622 | Mackie et al. | Oct 2003 | B2 |
6637056 | Tybinkowski et al. | Oct 2003 | B1 |
6646383 | Bertsche et al. | Nov 2003 | B2 |
6653547 | Akamatsu | Nov 2003 | B2 |
6661870 | Kapatoes et al. | Dec 2003 | B2 |
6688187 | Masquelier | Feb 2004 | B1 |
6690965 | Riaziat et al. | Feb 2004 | B1 |
6697452 | Feb 2004 | B2 | |
6705984 | Angha | Mar 2004 | B1 |
6713668 | Akamatsu | Mar 2004 | B2 |
6713976 | Zumoto et al. | Mar 2004 | B1 |
6714620 | Caflisch et al. | Mar 2004 | B2 |
6714629 | Vilsmeier | Mar 2004 | B2 |
6716162 | Hakamata | Apr 2004 | B2 |
6723334 | McGee et al. | Apr 2004 | B1 |
6741674 | Lee | May 2004 | B2 |
6760402 | Ghelmansarai | Jul 2004 | B2 |
6774383 | Norimine et al. | Aug 2004 | B2 |
6787771 | Bashkirov et al. | Sep 2004 | B2 |
6787983 | Yamanobe et al. | Sep 2004 | B2 |
6788764 | Saladin et al. | Sep 2004 | B2 |
6792073 | Deasy et al. | Sep 2004 | B2 |
6796164 | McLoughlin et al. | Sep 2004 | B2 |
6800866 | Amemiya et al. | Oct 2004 | B2 |
6822244 | Beloussov et al. | Nov 2004 | B2 |
6822247 | Sasaki | Nov 2004 | B2 |
6838676 | Jackson | Jan 2005 | B1 |
6842502 | Jaffray et al. | Jan 2005 | B2 |
6844689 | Brown et al. | Jan 2005 | B1 |
6871171 | Agur et al. | Mar 2005 | B1 |
6873115 | Sagawa et al. | Mar 2005 | B2 |
6873123 | Marchand et al. | Mar 2005 | B2 |
6878951 | Ma | Apr 2005 | B2 |
6882702 | Luo | Apr 2005 | B2 |
6882705 | Egley et al. | Apr 2005 | B2 |
6888326 | Amaldi et al. | May 2005 | B2 |
6889695 | Pankratov et al. | May 2005 | B2 |
6907282 | Siochi | Jun 2005 | B2 |
6922455 | Jurczyk et al. | Jul 2005 | B2 |
6929398 | Tybinkowski et al. | Aug 2005 | B1 |
6936832 | Norimine et al. | Aug 2005 | B2 |
6955464 | Tybinkowski et al. | Oct 2005 | B1 |
6963171 | Sagawa et al. | Nov 2005 | B2 |
6974254 | Paliwal et al. | Dec 2005 | B2 |
6984835 | Harada | Jan 2006 | B2 |
6990167 | Chen | Jan 2006 | B2 |
7015490 | Wang et al. | Mar 2006 | B2 |
7046762 | Lee | May 2006 | B2 |
7051605 | Lagraff et al. | May 2006 | B2 |
7060997 | Norimine et al. | Jun 2006 | B2 |
7077569 | Tybinkowski et al. | Jul 2006 | B1 |
7081619 | Bashkirov et al. | Jul 2006 | B2 |
7084410 | Beloussov et al. | Aug 2006 | B2 |
7087200 | Taboas et al. | Aug 2006 | B2 |
7112924 | Hanna | Sep 2006 | B2 |
7130372 | Kusch et al. | Oct 2006 | B2 |
7154991 | Earnst et al. | Dec 2006 | B2 |
7186986 | Hinderer et al. | Mar 2007 | B2 |
7186991 | Kato et al. | Mar 2007 | B2 |
7203272 | Chen | Apr 2007 | B2 |
7209547 | Baier et al. | Apr 2007 | B2 |
7221733 | Takai et al. | May 2007 | B1 |
7252307 | Kanbe et al. | Aug 2007 | B2 |
7257196 | Brown et al. | Aug 2007 | B2 |
7391026 | Trinkaus et al. | Jun 2008 | B2 |
20020007918 | Owen et al. | Jan 2002 | A1 |
20020077545 | Takahashi et al. | Jun 2002 | A1 |
20020080915 | Frohlich | Jun 2002 | A1 |
20020085668 | Blumhofer et al. | Jul 2002 | A1 |
20020091314 | Schlossbauer et al. | Jul 2002 | A1 |
20020115923 | Erbel | Aug 2002 | A1 |
20020120986 | Erbel et al. | Sep 2002 | A1 |
20020122530 | Erbel et al. | Sep 2002 | A1 |
20020136439 | Ruchala et al. | Sep 2002 | A1 |
20020150207 | Kapatoes et al. | Oct 2002 | A1 |
20020187502 | Waterman et al. | Dec 2002 | A1 |
20020193685 | Mate et al. | Dec 2002 | A1 |
20030007601 | Jaffray et al. | Jan 2003 | A1 |
20030031298 | Feb 2003 | A1 | |
20030086527 | Speiser et al. | May 2003 | A1 |
20030105650 | Lombardo et al. | Jun 2003 | A1 |
20030174872 | Chalana et al. | Sep 2003 | A1 |
20040010418 | Buonocore et al. | Jan 2004 | A1 |
20040068182 | Misra | Apr 2004 | A1 |
20040116804 | Mostafavi | Jun 2004 | A1 |
20040165696 | Lee | Aug 2004 | A1 |
20040202280 | Besson | Oct 2004 | A1 |
20040230115 | Scarantino et al. | Nov 2004 | A1 |
20040254492 | Zhang et al. | Dec 2004 | A1 |
20040254773 | Zhang et al. | Dec 2004 | A1 |
20040264640 | Myles | Dec 2004 | A1 |
20050013406 | Dyk et al. | Jan 2005 | A1 |
20050031181 | Bi et al. | Feb 2005 | A1 |
20050080332 | Shiu et al. | Apr 2005 | A1 |
20050096515 | Geng | May 2005 | A1 |
20050123092 | Mistretta et al. | Jun 2005 | A1 |
20050143965 | Failla et al. | Jun 2005 | A1 |
20050180544 | Sauer et al. | Aug 2005 | A1 |
20050197564 | Dempsey | Sep 2005 | A1 |
20050251029 | Khamene et al. | Nov 2005 | A1 |
20060074292 | Thomson et al. | Apr 2006 | A1 |
20060083349 | Harari et al. | Apr 2006 | A1 |
20060100738 | Alsafadi et al. | May 2006 | A1 |
20060133568 | Moore | Jun 2006 | A1 |
20060193429 | Chen | Aug 2006 | A1 |
20060193441 | Cadman | Aug 2006 | A1 |
20060285639 | Olivera et al. | Dec 2006 | A1 |
20070041494 | Ruchala et al. | Feb 2007 | A1 |
20070041495 | Olivera et al. | Feb 2007 | A1 |
20070041497 | Schnarr et al. | Feb 2007 | A1 |
20070041498 | Olivera et al. | Feb 2007 | A1 |
20070041499 | Lu et al. | Feb 2007 | A1 |
20070041500 | Olivera et al. | Feb 2007 | A1 |
20070043286 | Lu et al. | Feb 2007 | A1 |
20070076846 | Ruchala et al. | Apr 2007 | A1 |
20070088573 | Ruchala et al. | Apr 2007 | A1 |
20070104316 | Ruchala et al. | May 2007 | A1 |
20070127623 | Goldman et al. | Jun 2007 | A1 |
20070189591 | Lu et al. | Aug 2007 | A1 |
20070195922 | Mackie et al. | Aug 2007 | A1 |
20070195929 | Ruchala et al. | Aug 2007 | A1 |
20070195930 | Kapatoes et al. | Aug 2007 | A1 |
20070201613 | Lu et al. | Aug 2007 | A1 |
20070211857 | Urano et al. | Sep 2007 | A1 |
Number | Date | Country |
---|---|---|
2091275 | Sep 1993 | CA |
2180227 | Dec 1996 | CA |
03076003 | Sep 2003 | WO |
2004057515 | Jul 2004 | WO |
Number | Date | Country | |
---|---|---|---|
20070189591 A1 | Aug 2007 | US |
Number | Date | Country | |
---|---|---|---|
60701580 | Jul 2005 | US |